Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Steris Corp (STE)

Steris Corp (STE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 12,611,470
  • Shares Outstanding, K 84,783
  • Annual Sales, $ 2,782 M
  • Annual Income, $ 304,050 K
  • 60-Month Beta 0.88
  • Price/Sales 4.47
  • Price/Cash Flow 19.29
  • Price/Book 3.80

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 1.43
  • Number of Estimates 3
  • High Estimate 1.47
  • Low Estimate 1.39
  • Prior Year 1.26
  • Growth Rate Est. (year over year) +13.49%

Price Performance

See More
Period Period Low Period High Performance
1-Month
136.37 +9.08%
on 10/22/19
148.83 -0.05%
on 11/15/19
+5.65 (+3.95%)
since 10/15/19
3-Month
136.37 +9.08%
on 10/22/19
156.66 -5.05%
on 08/30/19
-3.22 (-2.12%)
since 08/15/19
52-Week
99.14 +50.03%
on 12/26/18
156.66 -5.05%
on 08/30/19
+30.60 (+25.90%)
since 11/15/18

Most Recent Stories

More News
DexCom (DXCM) Soars to 52-Week High, Time to Cash Out?

DexCom (DXCM) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

DXCM : 208.37 (+2.74%)
TMO : 306.81 (+1.98%)
EW : 245.64 (+2.11%)
STE : 148.75 (+1.37%)
STERIS' (STE) Q2 Earnings Surpass Estimates, FY20 View Up

STERIS (STE) witnesses solid revenue growth across each of its operating segments in the second quarter of fiscal 2020.

TMO : 306.81 (+1.98%)
EW : 245.64 (+2.11%)
RMD : 147.10 (+1.16%)
STE : 148.75 (+1.37%)
Steris (STE) Surpasses Q2 Earnings and Revenue Estimates

Steris (STE) delivered earnings and revenue surprises of 4.76% and 2.93%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

STE : 148.75 (+1.37%)
STERIS Announces Financial Results for Fiscal 2020 Second Quarter

-- Second quarter revenue grows 9% as reported, 10% constant currency organic;

STE : 148.75 (+1.37%)
STERIS to Host a Conference Call for Fiscal 2020 Second Quarter Financial Results on November 5, 2019

STERIS plc (NYSE: STE) ("STERIS" or the "Company") announced today that it will host a conference call to discuss its fiscal 2020 second quarter financial results at 10:00 a.m. Eastern Time on Tuesday,...

STE : 148.75 (+1.37%)
Steris (STE) Down 0.1% Since Last Earnings Report: Can It Rebound?

Steris (STE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

STE : 148.75 (+1.37%)
STERIS to Participate in the Morgan Stanley Global Healthcare Conference

STERIS plc (NYSE: STE) ("STERIS" or the "Company") announced that it will participate in the Morgan Stanley Global Healthcare Conference on Tuesday, September 10, 2019. Walt Rosebrough, STERIS's President...

MS : 48.99 (+0.78%)
STE : 148.75 (+1.37%)
STERIS (STE) Q1 Earnings Surpass Estimates, Margins Rise

STERIS (STE) witnesses solid revenue growth across each of its operating segments in Q1.

ISRG : 569.54 (+2.72%)
SYK : 206.25 (+1.52%)
BAX : 81.44 (+0.87%)
STE : 148.75 (+1.37%)
Steris (STE) Surpasses Q1 Earnings and Revenue Estimates

Steris (STE) delivered earnings and revenue surprises of 10.81% and 3.46%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

STE : 148.75 (+1.37%)
STERIS Announces Financial Results for Fiscal 2020 First Quarter

STERIS plc (NYSE: STE) ("STERIS" or the "Company") today announced financial results for its fiscal 2020 first quarter ended June 30, 2019. Revenue as reported for the quarter increased 9% to $696.8 million...

STE : 148.75 (+1.37%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Soft. Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade STE with:

Business Summary

Steris Plc provide infection prevention, contamination control, microbial reduction, and procedural support products and services for healthcare, pharmaceutical, scientific, research, industrial and governmental customers. The Company's operating segments consists of Healthcare, Life Sciences and STERIS...

See More

Key Turning Points

2nd Resistance Point 150.17
1st Resistance Point 149.46
Last Price 148.75
1st Support Level 147.41
2nd Support Level 146.06

See More

52-Week High 156.66
Last Price 148.75
Fibonacci 61.8% 134.69
Fibonacci 50% 127.90
Fibonacci 38.2% 121.12
52-Week Low 99.14

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar